Overexpression of TRIM44 is related to invasive potential and malignant outcomes in esophageal squamous cell carcinoma-Reference-Cited by-同舟云学术

Overexpression of TRIM44 is related to invasive potential and malignant outcomes in esophageal squamous cell carcinoma

Published:2017-06 Issue:6 Volume:39 Page:101042831770040
ISSN:1010-4283
Container-title:Tumor Biology
language:en
Short-container-title:Tumour Biol.

Author:

Kawaguchi Tsutomu¹,Komatsu Shuhei¹,Ichikawa Daisuke¹,Hirajima Shoji¹,Nishimura Yukihisa¹,Konishi Hirotaka¹,Shiozaki Atsushi¹,Fujiwara Hitoshi¹,Okamoto Kazuma¹,Tsuda Hitoshi²³,Otsuji Eigo¹

Affiliation:

1. Division of Digestive Surgery, Department of Surgery, Kyoto Prefectural University of Medicine, Kyoto, Japan

2. Department of Pathology, National Cancer Center Hospital, Tokyo, Japan

3. Department of Basic Pathology, National Defense Medical College, Saitama, Japan

Publisher

IOS Press

Subject

General Medicine

Link

http://journals.sagepub.com/doi/pdf/10.1177/1010428317700409

Reference37 articles.

1. Global cancer statistics

2. The ubiquitin-mediated proteolytic pathway and mechanisms of energy-dependent intracellular protein degradation

3. Conjugation of [125I]ubiquitin to cellular proteins in permeabilized mammalian cells: comparison of mitotic and interphase cells.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TRIM44, a Novel Prognostic Marker, Supports the Survival of Proteasome-Resistant Multiple Myeloma Cells;Cells;2024-08-26

2. TRIM44 enhances autophagy via SQSTM1 oligomerization in response to oxidative stress;Scientific Reports;2024-08-16

3. Intricate confrontation: Research progress and application potential of TRIM family proteins in tumor immune escape;Journal of Advanced Research;2023-12

4. TRIM44 Promotes Endometrial Carcinoma Progression by Activating the FRS2 Signalling Pathway;Evidence-Based Complementary and Alternative Medicine;2022-11-07

5. Cardiac-specific Trim44 knockout in rat attenuates isoproterenol-induced cardiac remodeling via inhibition of AKT/mTOR pathway;Disease Models & Mechanisms;2022-08-18